Perrigo to switch to NYSE from Nasdaq
The pharmaceutical company will transfer its listing to the New York Stock Exchange on June 6.
Perrigo chairman and CEO Joseph Papa said, "We are looking forward to listing on the NYSE as this change will provide increased visibility and enhanced services that will benefit our shareholders. We remain committed to making quality healthcare more affordable for our customers and patients and continuing to increase shareholder value."
"Perrigo and the NYSE are a perfect fit, and we're thrilled to welcome one of the world's leading healthcare suppliers to the world's leading equities market," said NYSE Euronext CEO Duncan Niederauer. "Perrigo was founded more than a century ago seeking to best serve and empower customers, continually innovate, and deliver quality products. That vision, which remains in place today, set the stage for the company's growth and global leadership."
Published by Globes [online], Israel business news - www.globes-online.com - on May 23, 2013
© Copyright of Globes Publisher Itonut (1983) Ltd. 2013
- Tel Aviv market report
- Tel Aviv Stock Exchange
- Israeli stocks in NY
- Arbitrage gaps for dual-listed stocks
- Israeli stocks in Europe
- Israeli stocks on other markets
- Tel Aviv 25 options
- Mutual funds
- Current representative shekel rates
- Historical representative shekel rates
- Bank shekel rates
- Shekel/dollar options